Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application

This article is licensed under aCreative Commons Attribution-NonCommercial 3.0 Unported Licence.Taslim A. Al-Hilal, Ali Keshavarz, Hossam Kadry, Behnaz Lahooti, Ahmed Al-Obaida, Zhenya Ding, Wei Li, Roger Kamm, Ivan F. McMurtry, Tim Lahm, Eva Nozik-Grayck, Kurt R. Stenmark, Fakhrul Ahsan Current animal and cellular models only partially recapitulate the pathophysiology of PAH. Our PAH-on-a-chip model can mimic the major pathologies of PAH such as pulmonary arterial remodeling and sex disparity and help develop PAH therapeutics. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry

Source: RSC - Lab Chip latest articles - August 4, 2020 Category: Chemistry Authors: Taslim A. Al-Hilal Source Type: research